Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Parkinson's Disease

Free Subscription Articles published in Neurology Retrieve available abstracts of 206 articles: HTML format

Single Articles

April 2008
1. GAN-OR Z , Giladi N, Rozovski U, Shifrin C, et al
   Genotype--phenotype correlations between GBA mutations and Parkinson disease risk and onset.
   Neurology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. MOREAU C , Defebvre L, Destee A, Bleuse S, et al
   STN-DBS frequency effects on freezing of gait in advanced Parkinson disease.
   Neurology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. NING YP , Kanai K, Tomiyama H, Li Y, et al
   PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype.
   Neurology. 2008;70.
   PubMed     Related articles   
   
   
   
4. GUEHL D , Vital A, Cuny E, Spampinato U, et al
   Postmortem proof of effectiveness of zona incerta stimulation in Parkinson disease.
   Neurology. 2008;70.
   PubMed     Related articles   
   
   
   
5. NANDHAGOPAL R , McKeown MJ, Stoessl AJ
   Invited article: Functional imaging in Parkinson disease.
   Neurology. 2008;70.
   PubMed     Related articles    Abstract available
   
   
   
6. POTTER M , Herzog J, Siebner HR, Kopper F, et al
   Subthalamic nucleus stimulation modulates audiospinal reactions in Parkinson disease.
   Neurology. 2008;70.
   PubMed     Related articles    Abstract available
   
   
   
7. FERRAYE MU , Debu B, Fraix V, Xie-Brustolin J, et al
   Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease.
   Neurology. 2008;70.
   PubMed     Related articles    Abstract available
   
   
   
8. DRIVER JA , Kurth T, Buring JE, Gaziano JM, et al
   Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study.
   Neurology. 2008;70.
   PubMed     Related articles    Abstract available
   
   
   
9. EBERLING JL , Jagust WJ, Christine CW, Starr P, et al
   Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.
   Neurology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. HU G , Antikainen R, Jousilahti P, Kivipelto M, et al
    Total cholesterol and the risk of Parkinson disease.
    Neurology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. PAPAPETROPOULOS S , Jagid JR, Sengun C, Singer C, et al
    Objective monitoring of tremor and bradykinesia during DBS surgery for Parkinson disease.
    Neurology. 2008;70:1244-9.
    PubMed     Related articles    Abstract available
    
    
    
12. MORO E , Volkmann J, Konig IR, Winkler S, et al
    Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism.
    Neurology. 2008;70:1186-91.
    PubMed     Related articles    Abstract available
    
    
    March 2008
13. HUANG C , Mattis P, Perrine K, Brown N, et al
    Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease.
    Neurology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. BUTER TC , van den Hout A, Matthews FE, Larsen JP, et al
    Dementia and survival in Parkinson disease: a 12-year population study.
    Neurology. 2008;70:1017-22.
    PubMed     Related articles    Abstract available
    
    
    
15. ZACCAI J , Brayne C, McKeith I, Matthews F, et al
    Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
    Neurology. 2008;70:1042-8.
    PubMed     Related articles    Abstract available
    
    
    
16. HAUGARVOLL K , Rademakers R, Kachergus JM, Nuytemans K, et al
    Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.
    Neurology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. BRIGHINA L , Frigerio R, Schneider NK, Lesnick TG, et al
    {alpha}-Synuclein, pesticides, and Parkinson disease. A case-control study.
    Neurology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
18. KOMPOLITI K
    Diagnosis and management of Parkinson's disease.
    Neurology. 2008;70:739.
    PubMed     Related articles   
    
    
    
19. ALVAREZ MV , Evidente VG
    Understanding drug-induced parkinsonism: Separating pearls from oy-sters.
    Neurology. 2008;70:e32-34.
    PubMed     Related articles   
    
    
    
20. BECKER C , Jick SS, Meier CR
    Use of antihypertensives and the risk of Parkinson disease.
    Neurology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. FRIEDMAN JH , Amick MM, Chou KL
    Rhinorrhea and olfaction in Parkinson disease.
    Neurology. 2008;70:487-9.
    PubMed     Related articles   
    
    
    
22. THURMAN DJ , Stevens JA, Rao JK
    Practice parameter: Assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Neurology. 2008;70:473-9.
    PubMed     Related articles    Abstract available
    
    
    January 2008
23. RANSMAYR GN , Holliger S, Schletterer K, Heidler H, et al
    Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease.
    Neurology. 2008;70:299-303.
    PubMed     Related articles    Abstract available
    
    
    
24. OBI T , Nishioka K, Ross OA, Terada T, et al
    Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia.
    Neurology. 2008;70:238-41.
    PubMed     Related articles   
    
    
    
25. WAHNER AD , Bronstein JM, Bordelon YM, Ritz B, et al
    Statin use and the risk of Parkinson disease.
    Neurology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. RAJPUT AH , Sitte HH, Rajput AH, Fenton ME, et al
    Globus pallidus dopamine and Parkinson motor subtypes. Clinical and brain biochemical correlation.
    Neurology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. MARTIN WR , Wieler M, Gee M
    Midbrain iron content in early Parkinson disease. A potential biomarker of disease status.
    Neurology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. THEUNS J , Van Broeckhoven C
    {alpha}-Synuclein gene duplications in sporadic Parkinson disease.
    Neurology. 2008;70:7-9.
    PubMed     Related articles   
    
    
    December 2007
29. SCHESTATSKY P , Kumru H, Valls-Sole J, Valldeoriola F, et al
    Neurophysiologic study of central pain in patients with Parkinson disease.
    Neurology. 2007;69:2162-9.
    PubMed     Related articles    Abstract available
    
    
    
30. WEISSCHER N , Post B, de Haan RJ, Glas CA, et al
    The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease.
    Neurology. 2007;69:2155-61.
    PubMed     Related articles    Abstract available
    
    
    November 2007
31. BAUMER T , Pramstaller PP, Siebner HR, Schippling S, et al
    Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study.
    Neurology. 2007;69:1976-81.
    PubMed     Related articles    Abstract available
    
    
    
32. 
    Highlights of the November 20 issue.
    Neurology. 2007;69:1965.
    PubMed     Related articles   
    
    
    
33. VENDETTE M , Gagnon JF, Decary A, Massicotte-Marquez J, et al
    REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.
    Neurology. 2007;69:1843-9.
    PubMed     Related articles    Abstract available
    
    
    
34. WAHNER AD , Bronstein JM, Bordelon YM, Ritz B, et al
    Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease.
    Neurology. 2007;69:1836-42.
    PubMed     Related articles    Abstract available
    
    
    October 2007
35. FARRER MJ
    Lrrk2 in the limelight!
    Neurology. 2007;69:1732-3.
    PubMed     Related articles   
    
    
    
36. AHLSKOG JE
    Beating a dead horse: dopamine and Parkinson disease.
    Neurology. 2007;69:1701-11.
    PubMed     Related articles    Abstract available
    
    
    
37. ALONSO A , Rodriguez LA, Logroscino G, Hernan MA, et al
    Gout and risk of Parkinson disease: a prospective study.
    Neurology. 2007;69:1696-700.
    PubMed     Related articles    Abstract available
    
    
    
38. ORR-URTREGER A , Shifrin C, Rozovski U, Rosner S, et al
    The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Neurology. 2007;69:1595-602.
    PubMed     Related articles    Abstract available
    
    
    
39. WIJEMANNE S , Jankovic J
    Hemiparkinsonism-hemiatrophy syndrome.
    Neurology. 2007;69:1585-94.
    PubMed     Related articles    Abstract available
    
    
    
40. AHLSKOG JE
    I can't get no satisfaction: still no neuroprotection for Parkinson disease.
    Neurology. 2007;69:1476-7.
    PubMed     Related articles   
    
    
    
41. DEVOS H , Vandenberghe W, Nieuwboer A, Tant M, et al
    Predictors of fitness to drive in people with Parkinson disease.
    Neurology. 2007;69:1434-41.
    PubMed     Related articles    Abstract available
    
    
    September 2007
42. MCGUIRE D
    Black substance.
    Neurology. 2007;69:1380.
    PubMed     Related articles   
    
    
    
43. 
    Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. CLARK LN , Ross BM, Wang Y, Mejia-Santana H, et al
    Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Neurology. 2007;69:1270-7.
    PubMed     Related articles    Abstract available
    
    
    
45. WINKLER S , Hagenah J, Lincoln S, Heckman M, et al
    {alpha}-Synuclein and Parkinson disease susceptibility.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. LUOMA PT , Eerola J, Ahola S, Hakonen AH, et al
    Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease.
    Neurology. 2007;69:1152-9.
    PubMed     Related articles    Abstract available
    
    
    
47. NICHOLS WC , Elsaesser VE, Pankratz N, Pauciulo MW, et al
    LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
48. KLEIN C , Schlossmacher MG
    Parkinson disease, 10 years after its genetic revolution. Multiple clues to a complex disorder.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. SIMON KC , Chen H, Schwarzschild M, Ascherio A, et al
    Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. ROCCA WA , Bower JH, Maraganore DM, Ahlskog JE, et al
    Increased risk of parkinsonism in women who underwent oophorectomy before menopause.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. BEUKERS RJ , Weisfelt M, de Bie RM
    Neurosurgery at an earlier stage of Parkinson disease.
    Neurology. 2007;69:811-2.
    PubMed     Related articles   
    
    
    
52. SWASH M
    Limb-kinetic apraxia in Parkinson disease.
    Neurology. 2007;69:810-1.
    PubMed     Related articles   
    
    
    
53. BEYER MK , Larsen JP, Aarsland D
    Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Neurology. 2007;69:747-54.
    PubMed     Related articles    Abstract available
    
    
    
54. SEPPI K , Rascol O
    Dementia with Lewy bodies and Parkinson disease with dementia: can MRI make the difference?
    Neurology. 2007;69:717-8.
    PubMed     Related articles   
    
    
    
55. INZELBERG R , Jankovic J
    Are Parkinson disease patients protected from some but not all cancers?
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. BURKE WJ
    The progression of Parkinson disease: a hypothesis.
    Neurology. 2007;69:710-1.
    PubMed     Related articles   
    
    
    
57. GOY ER , Carter JH, Ganzini L
    Parkinson disease at the end of life: caregiver perspectives.
    Neurology. 2007;69:611-2.
    PubMed     Related articles   
    
    
    
58. KATZENSCHLAGER R , Schrag A, Evans A, Manson A, et al
    Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure.
    Neurology. 2007;69:555-63.
    PubMed     Related articles    Abstract available
    
    
    July 2007
59. KEMPSTER PA , Hurwitz B, Lees AJ
    A new look at James Parkinson's Essay on the Shaking Palsy.
    Neurology. 2007;69:482-5.
    PubMed     Related articles    Abstract available
    
    
    
60. VERBAAN D , Marinus J, Visser M, van Rooden SM, et al
    Patient-reported autonomic symptoms in Parkinson disease.
    Neurology. 2007;69:333-41.
    PubMed     Related articles    Abstract available
    
    
    
61. KARCESKI S
    Early Parkinson disease and depression.
    Neurology. 2007;69:E2-3.
    PubMed     Related articles   
    
    
    
62. SHANNON KM
    Dopamine: so "last century".
    Neurology. 2007;69:329-30.
    PubMed     Related articles   
    
    
    
63. BENARROCH E
    Endocannabinoids in basal ganglia circuits: implications for Parkinson disease.
    Neurology. 2007;69:306-9.
    PubMed     Related articles   
    
    
    
64. GOLDSTEIN DS , Imrich R, Peckham E, Holmes C, et al
    Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. AHN TB , Kim SY, Kim JY, Park SS, et al
    {alpha}-Synuclein gene duplication is present in sporadic Parkinson disease.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. CALABRESE VP
    Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.
    Neurology. 2007;69:223-4.
    PubMed     Related articles   
    
    
    
67. KAYE JA , Moore MM, Galasko D, Craig UK, et al
    Brain volumes in Guam dementia vs Parkinson dementia complex vs aging Chamorro adults.
    Neurology. 2007;69:196-9.
    PubMed     Related articles    Abstract available
    
    
    
68. BIGLAN KM , Holloway RG Jr, McDermott MP, Richard IH, et al
    Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.
    Neurology. 2007;69:187-95.
    PubMed     Related articles    Abstract available
    
    
    
69. SENOL MG , Togrol RE
    Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study.
    Neurology. 2007;69:117.
    PubMed     Related articles   
    
    
    June 2007
70. RAVINA B , Camicioli R, Como PG, Marsh L, et al
    The impact of depressive symptoms in early Parkinson disease.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. CHARLES P , Camuzat A, Benammar N, Sellal F, et al
    Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. IKEDA K , Kashihara H, Tamura M, Kano O, et al
    Body mass index and the risk of Parkinson disease.
    Neurology. 2007;68:2156.
    PubMed     Related articles   
    
    
    
73. HEILMAN K , Quencer K, Okun MS, Crucian G, et al
    Is decreased dexterity in Parkinson disease due to apraxia?
    Neurology. 2007;68:2044.
    PubMed     Related articles   
    
    
    
74. MINGUEZ-CASTELLANOS A , Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, et al
    Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.
    Neurology. 2007;68:2012-8.
    PubMed     Related articles    Abstract available
    
    
    May 2007
75. OAKLEY AE , Collingwood JF, Dobson J, Love G, et al
    Individual dopaminergic neurons show raised iron levels in Parkinson disease.
    Neurology. 2007;68:1820-5.
    PubMed     Related articles    Abstract available
    
    
    
76. DI FONZO A , Chien HF, Socal M, Giraudo S, et al
    ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
    Neurology. 2007;68:1557-62.
    PubMed     Related articles    Abstract available
    
    
    
77. DUKER AP , Espay AJ
    Parkinsonism associated with striatal perivascular space dilation.
    Neurology. 2007;68:1540.
    PubMed     Related articles   
    
    
    
78. BRUSA L , Petta F, Pisani A, Moschella V, et al
    Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease.
    Neurology. 2007;68:1455-9.
    PubMed     Related articles    Abstract available
    
    
    April 2007
79. KURLAN R , Cummings J, Raman R, Thal L, et al
    Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Neurology. 2007;68:1356-63.
    PubMed     Related articles    Abstract available
    
    
    
80. DEROST PP , Ouchchane L, Morand D, Ulla M, et al
    Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
    Neurology. 2007;68:1345-55.
    PubMed     Related articles    Abstract available
    
    
    
81. DI ROCCO A , Werner P
    Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.
    Neurology. 2007;68:1440.
    PubMed     Related articles   
    
    
    
82. ROSENKILDE CE
    Atypical antipsychotics in the elderly with Parkinson disease and the "black box" warning.
    Neurology. 2007;68:1325.
    PubMed     Related articles   
    
    
    
83. LEWITT PA , Lyons KE, Pahwa R
    Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study.
    Neurology. 2007;68:1262-7.
    PubMed     Related articles    Abstract available
    
    
    
84. SMEDING HM , van den Munckhof P, Esselink RA, Schmand B, et al
    Reversible cognitive decline after DBS STN in PD and displacement of electrodes.
    Neurology. 2007;68:1235-6.
    PubMed     Related articles   
    
    
    
85. JABRE MG , Bejjani BP
    Neurosurgery in Parkinson disease: a distressed mind in a repaired body?
    Neurology. 2007;68:1164.
    PubMed     Related articles   
    
    
    
86. PAHWA R , Stacy MA, Factor SA, Lyons KE, et al
    Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease.
    Neurology. 2007;68:1108-15.
    PubMed     Related articles    Abstract available
    
    
    
87. GOLDWURM S , Zini M, Mariani L, Tesei S, et al
    Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease.
    Neurology. 2007;68:1141-3.
    PubMed     Related articles    Abstract available
    
    
    March 2007
88. SAWAMOTO N , Honda M, Hanakawa T, Aso T, et al
    Cognitive slowing in Parkinson disease is accompanied by hypofunctioning of the striatum.
    Neurology. 2007;68:1062-8.
    PubMed     Related articles    Abstract available
    
    
    
89. FIDDIAN-GREEN RG
    Helicobacter pylori eradication and L-dopa absorption in patients with PD and motor fluctuations.
    Neurology. 2007;68:1085.
    PubMed     Related articles   
    
    
    
90. CHOU KL , Stacy MA
    Skin rash associated with Sinemet does not equal levodopa allergy.
    Neurology. 2007;68:1078-9.
    PubMed     Related articles   
    
    
    
91. LANG AE
    The progression of Parkinson disease: a hypothesis.
    Neurology. 2007;68:948-52.
    PubMed     Related articles    Abstract available
    
    
    
92. SATO Y , Honda Y, Iwamoto J
    Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.
    Neurology. 2007;68:911-5.
    PubMed     Related articles    Abstract available
    
    
    
93. RIGGS JE , Gutmann L, Hobbs GR
    Volunteering for early phase gene transfer research in Parkinson disease.
    Neurology. 2007;68:877.
    PubMed     Related articles   
    
    
    
94. LIPPA CF , Duda JE, Grossman M, Hurtig HI, et al
    DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.
    Neurology. 2007;68:812-9.
    PubMed     Related articles    Abstract available
    
    
    
95. THACKER EL , O'Reilly EJ, Weisskopf MG, Chen H, et al
    Temporal relationship between cigarette smoking and risk of Parkinson disease.
    Neurology. 2007;68:764-8.
    PubMed     Related articles    Abstract available
    
    
    February 2007
96. ALFONSI E , Versino M, Merlo IM, Pacchetti C, et al
    Electrophysiologic patterns of oral-pharyngeal swallowing in parkinsonian syndromes.
    Neurology. 2007;68:583-9.
    PubMed     Related articles    Abstract available
    
    
    
97. MATZLER W , Nagele T, Gasser T, Kruger R, et al
    Acute parkinsonism with corresponding lesions in the basal ganglia after heroin abuse.
    Neurology. 2007;68:414.
    PubMed     Related articles   
    
    
    January 2007
98. SAILER A , Cunic DI, Paradiso GO, Gunraj CA, et al
    Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease.
    Neurology. 2007;68:356-63.
    PubMed     Related articles    Abstract available
    
    
    
99. RILEY D , Lozano A
    The fourth dimension of stereotaxis: timing of neurosurgery for Parkinson disease.
    Neurology. 2007;68:252-3.
    PubMed     Related articles   
    
    
    
100. MONTGOMERY EB JR
     Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2007;68:164.
     PubMed     Related articles   
     
     
     
101. LANDAU WM , Mink JW
     Is decreased dexterity in Parkinson disease due to apraxia?
     Neurology. 2007;68:90-1.
     PubMed     Related articles   
     
     
     
102. WATTS RL , Jankovic J, Waters C, Rajput A, et al
     Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease.
     Neurology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. AARSLAND D , Emre M, Lees A, Poewe W, et al
     Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2007;68:80.
     PubMed     Related articles   
     
     
     
104. HORVATH R , Kley RA, Lochmuller H, Vorgerd M, et al
     Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys.
     Neurology. 2007;68:56-8.
     PubMed     Related articles    Abstract available
     
     
     
105. MURATA M , Hasegawa K, Kanazawa I
     Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.
     Neurology. 2007;68:45-50.
     PubMed     Related articles    Abstract available
     
     
     
106. 
     A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.
     Neurology. 2007;68:20-8.
     PubMed     Related articles    Abstract available
     
     
     December 2006
107. MONTGOMERY EB JR
     Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2006;67:2266.
     PubMed     Related articles   
     
     
     
108. WILK JB , Tobin JE, Suchowersky O, Shill HA, et al
     Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.
     Neurology. 2006;67:2206-10.
     PubMed     Related articles    Abstract available
     
     
     
109. BLAIN CR , Barker GJ, Jarosz JM, Coyle NA, et al
     Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI.
     Neurology. 2006;67:2199-205.
     PubMed     Related articles    Abstract available
     
     
     
110. MIYAMOTO T , Miyamoto M, Inoue Y, Usui Y, et al
     Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder.
     Neurology. 2006;67:2236-8.
     PubMed     Related articles    Abstract available
     
     
     
111. SCHULTE C , Sharma M, Mueller JC, Lichtner P, et al
     Comprehensive association analysis of the NOS2A gene with Parkinson disease.
     Neurology. 2006;67:2080-2.
     PubMed     Related articles    Abstract available
     
     
     
112. BOSTANTJOPOULOU S , Katsarou Z, Petridis A, Andreou A, et al
     Aneurysm presenting as parkinsonism.
     Neurology. 2006;67:2028.
     PubMed     Related articles   
     
     
     
113. HU G , Jousilahti P, Nissinen A, Antikainen R, et al
     Body mass index and the risk of Parkinson disease.
     Neurology. 2006;67:1955-9.
     PubMed     Related articles    Abstract available
     
     
     
114. BALLARD C , Ziabreva I, Perry R, Larsen JP, et al
     Differences in neuropathologic characteristics across the Lewy body dementia spectrum.
     Neurology. 2006;67:1931-4.
     PubMed     Related articles    Abstract available
     
     
     
115. LIPPA CF , Emre M
     Characterizing clinical phenotypes: the Lewys in their life or the life of their Lewys?
     Neurology. 2006;67:1910-1.
     PubMed     Related articles   
     
     
     
116. SCHUPBACH WM , Maltete D, Houeto JL, Tezenas du Montcel S, et al
     Neurosurgery at an earlier stage of Parkinson disease. A randomized, controlled trial.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
117. QUENCER K , Okun M, Crucian G, Fernandez H, et al
     Limb-kinetic apraxia in Parkinson disease.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     November 2006
118. STEMPER B , Beric A, Welsch G, Haendl T, et al
     Deep brain stimulation improves orthostatic regulation of patients with Parkinson disease.
     Neurology. 2006;67:1781-5.
     PubMed     Related articles    Abstract available
     
     
     
119. UC EY , Rizzo M, Anderson SW, Sparks JD, et al
     Driving with distraction in Parkinson disease.
     Neurology. 2006;67:1774-80.
     PubMed     Related articles    Abstract available
     
     
     
120. PAVESE N , Evans AH, Tai YF, Hotton G, et al
     Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study.
     Neurology. 2006;67:1612-7.
     PubMed     Related articles    Abstract available
     
     
     
121. GALVIN JE , Pollack J, Morris JC
     Clinical phenotype of Parkinson disease dementia.
     Neurology. 2006;67:1605-11.
     PubMed     Related articles    Abstract available
     
     
     
122. MAZZA S , Soucy JP, Gravel P, Michaud M, et al
     Assessing whole brain perfusion changes in patients with REM sleep behavior disorder.
     Neurology. 2006;67:1618-22.
     PubMed     Related articles    Abstract available
     
     
     
123. DORSEY ER , Constantinescu R, Thompson JP, Biglan KM, et al
     Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     October 2006
124. RAJPUT A , Dickson DW, Robinson CA, Ross OA, et al
     Parkinsonism, Lrrk2 G2019S, and tau neuropathology.
     Neurology. 2006;67:1506-8.
     PubMed     Related articles    Abstract available
     
     
     
125. PREHN AW , Vawter DE, Gervais KG, DeVries RG, et al
     Studying neurosurgical implants for Parkinson disease: a question of design.
     Neurology. 2006;67:1503-5.
     PubMed     Related articles    Abstract available
     
     
     
126. SPANAKI C , Latsoudis H, Plaitakis A
     LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP.
     Neurology. 2006;67:1518-9.
     PubMed     Related articles   
     
     
     
127. CLARK LN , Wang Y, Karlins E, Saito L, et al
     Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
128. FARIELLO RG , Lieberman A
     Present and future approaches to Parkinson disease: from molecular insights to new therapeutic avenues.
     Neurology. 2006;67.
     PubMed     Related articles   
     
     
     
129. BENDER A , Koch W, Elstner M, Schombacher Y, et al
     Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.
     Neurology. 2006;67:1262-4.
     PubMed     Related articles    Abstract available
     
     
     
130. PONTONE G , Williams JR, Bassett SS, Marsh L, et al
     Clinical features associated with impulse control disorders in Parkinson disease.
     Neurology. 2006;67:1258-61.
     PubMed     Related articles    Abstract available
     
     
     
131. YAMAMOTO M , Uesugi T, Nakayama T
     Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study.
     Neurology. 2006;67:1225-9.
     PubMed     Related articles    Abstract available
     
     
     
132. BLACK KJ , Friedman JH
     Repetitive and impulsive behaviors in treated Parkinson disease.
     Neurology. 2006;67:1118-9.
     PubMed     Related articles   
     
     
     
133. ZECCA L , Zucca FA, Albertini A, Rizzio E, et al
     A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease.
     Neurology. 2006;67.
     PubMed     Related articles    Abstract available
     
     
     
134. BONUCCELLI U , Del Dotto P
     New pharmacologic horizons in the treatment of Parkinson disease.
     Neurology. 2006;67.
     PubMed     Related articles    Abstract available
     
     
     
135. STOCCHI F , Vacca L, Grassini P, De Pandis MF, et al
     Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition.
     Neurology. 2006;67.
     PubMed     Related articles    Abstract available
     
     
     
136. CACCIA C , Maj R, Calabresi M, Maestroni S, et al
     Safinamide: from molecular targets to a new anti-Parkinson drug.
     Neurology. 2006;67.
     PubMed     Related articles    Abstract available
     
     
     
137. SOTNIKOVA TD , Caron MG, Gainetdinov RR
     DDD mice, a novel acute mouse model of Parkinson's disease.
     Neurology. 2006;67.
     PubMed     Related articles    Abstract available
     
     
     September 2006
138. DELVAL A , Defebvre L, Labyt E, Douay X, et al
     Movement-related cortical activation in familial Parkinson disease.
     Neurology. 2006;67:1086-7.
     PubMed     Related articles    Abstract available
     
     
     
139. DELEU D , Jacob P, Chand P, Sarre S, et al
     Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease.
     Neurology. 2006;67:897-9.
     PubMed     Related articles    Abstract available
     
     
     
140. GJERSTAD MD , Alves G, Wentzel-Larsen T, Aarsland D, et al
     Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
     Neurology. 2006;67:853-8.
     PubMed     Related articles    Abstract available
     
     
     
141. GOKER-ALPAN O , Giasson BI, Eblan MJ, Nguyen J, et al
     Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.
     Neurology. 2006;67:908-10.
     PubMed     Related articles    Abstract available
     
     
     
142. VOON V , Hassan K, Zurowski M, de Souza M, et al
     Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     August 2006
143. TIANGYOU W , Hudson G, Ghezzi D, Ferrari G, et al
     POLG1 in idiopathic Parkinson disease.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
144. PRODAN CI , Monnot M, Ross ED, Coleman AE, et al
     Reversible dementia with parkinsonian features associated with budesonide use.
     Neurology. 2006;67:723.
     PubMed     Related articles   
     
     
     
145. FRIEDMAN JH
     Atypical antipsychotics in the elderly with Parkinson disease and the "black box" warning.
     Neurology. 2006;67:564-6.
     PubMed     Related articles    Abstract available
     
     
     
146. BOWER JH , Maraganore DM, Peterson BJ, Ahlskog JE, et al
     Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study.
     Neurology. 2006;67:494-6.
     PubMed     Related articles    Abstract available
     
     
     
147. HAINES S , Chen H, Anderson KE, Fishman PS, et al
     When do patients with Parkinson disease disclose their diagnosis?
     Neurology. 2006;67:488-90.
     PubMed     Related articles    Abstract available
     
     
     July 2006
148. DE LAU LM , Koudstaal PJ, Witteman JC, Hofman A, et al
     Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease.
     Neurology. 2006;67:315-8.
     PubMed     Related articles    Abstract available
     
     
     
149. SHOULSON I
     CEP-1347 Treatment Fails to Favorably Modify the Progression of Parkinson's Disease (PRECEPT) Study: S61.003.
     Neurology. 2006;67:185.
     PubMed     Related articles   
     
     
     
150. BRONSTEIN JM , Chou AP
     Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease.
     Neurology. 2006;67:182.
     PubMed     Related articles   
     
     
     
151. CHILOVI BV , Rozzini L, Padovani A
     Parkinsonian signs in subjects with mild cognitive impairment.
     Neurology. 2006;67:182-3.
     PubMed     Related articles   
     
     
     
152. MELLICK GD , Gartner CE, Silburn PA, Battistutta D, et al
     Passive smoking and Parkinson disease.
     Neurology. 2006;67:179-80.
     PubMed     Related articles   
     
     
     
153. KIRSCH-DARROW L , Fernandez HF, Marsiske M, Okun MS, et al
     Dissociating apathy and depression in Parkinson disease.
     Neurology. 2006;67:33-8.
     PubMed     Related articles    Abstract available
     
     
     
154. RICHARD IH
     Apathy does not equal depression in Parkinson disease: why we should care.
     Neurology. 2006;67:10-1.
     PubMed     Related articles   
     
     
     
155. MORGAN JC , Sethi KD
     Pergolide-induced ergotism.
     Neurology. 2006;67:104.
     PubMed     Related articles   
     
     
     June 2006
156. SMEDING HM , Speelman JD, Koning-Haanstra M, Schuurman PR, et al
     Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study.
     Neurology. 2006;66:1830-6.
     PubMed     Related articles    Abstract available
     
     
     
157. SCHUPBACH M , Gargiulo M, Welter ML, Mallet L, et al
     Neurosurgery in Parkinson disease: a distressed mind in a repaired body?
     Neurology. 2006;66:1811-6.
     PubMed     Related articles    Abstract available
     
     
     
158. HAGENAH JM , Hedrich K, Becker B, Pramstaller PP, et al
     Distinguishing early-onset PD from dopa-responsive dystonia with transcranial sonography.
     Neurology. 2006;66:1951-2.
     PubMed     Related articles   
     
     
     
159. POSTUMA RB , Espay AJ, Zadikoff C, Suchowersky O, et al
     Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.
     Neurology. 2006;66:1941-3.
     PubMed     Related articles    Abstract available
     
     
     
160. YOSHITA M , Taki J, Yokoyama K, Noguchi-Shinohara M, et al
     Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
     Neurology. 2006;66:1850-4.
     PubMed     Related articles    Abstract available
     
     
     
161. PIERANTOZZI M , Pietroiusti A, Brusa L, Galati S, et al
     Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.
     Neurology. 2006;66:1824-9.
     PubMed     Related articles    Abstract available
     
     
     
162. SAINT-CYR JA , Albanese A
     STN DBS in PD: selection criteria for surgery should include cognitive and psychiatric factors.
     Neurology. 2006;66:1799-800.
     PubMed     Related articles   
     
     
     
163. LANDAU W
     What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports.
     Neurology. 2006;66:1788-9.
     PubMed     Related articles   
     
     
     
164. VOON V , Hassan K, Zurowski M, Duff-Canning S, et al
     Prospective prevalence of pathologic gambling and medication association in Parkinson disease.
     Neurology. 2006;66:1750-2.
     PubMed     Related articles    Abstract available
     
     
     
165. FREGNI F , Ono CR, Santos CM, Bermpohl F, et al
     Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD.
     Neurology. 2006;66:1629-37.
     PubMed     Related articles    Abstract available
     
     
     May 2006
166. ZABETIAN CP , Morino H, Ujike H, Yamamoto M, et al
     Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
167. DASS B , Olanow CW, Kordower JH
     Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease.
     Neurology. 2006;66.
     PubMed     Related articles    Abstract available
     
     
     
168. OLANOW CW
     Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease.
     Neurology. 2006;66.
     PubMed     Related articles    Abstract available
     
     
     
169. HAUSER RA , Zesiewicz TA
     Clinical trials aimed at detecting neuroprotection in Parkinson's disease.
     Neurology. 2006;66.
     PubMed     Related articles    Abstract available
     
     
     
170. KIEBURTZ K
     Issues in neuroprotection clinical trials in Parkinson's disease.
     Neurology. 2006;66.
     PubMed     Related articles    Abstract available
     
     
     
171. MCNAUGHT KS , Jackson T, JnoBaptiste R, Kapustin A, et al
     Proteasomal dysfunction in sporadic Parkinson's disease.
     Neurology. 2006;66.
     PubMed     Related articles    Abstract available
     
     
     
172. JENNER P , Olanow CW
     The pathogenesis of cell death in Parkinson's disease.
     Neurology. 2006;66.
     PubMed     Related articles    Abstract available
     
     
     
173. POEWE W
     The need for neuroprotective therapies in Parkinson's disease: a clinical perspective.
     Neurology. 2006;66.
     PubMed     Related articles    Abstract available
     
     
     
174. SCHAPIRA AH
     Etiology of Parkinson's disease.
     Neurology. 2006;66.
     PubMed     Related articles    Abstract available
     
     
     
175. OLANOW CW
     Prospects for neuroprotection in Parkinson's disease.
     Neurology. 2006;66.
     PubMed     Related articles   
     
     
     
176. SIDEROWF A , Stern M
     Clinical trials with rasagiline: evidence for short-term and long-term effects.
     Neurology. 2006;66.
     PubMed     Related articles    Abstract available
     
     
     
177. DELEU D , Hanssens Y
     Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
     Neurology. 2006;66:1611-2.
     PubMed     Related articles   
     
     
     
178. NUTT JG
     Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
     Neurology. 2006;66:1611-2.
     PubMed     Related articles   
     
     
     
179. GOETZ CG , Schwid SR, Eberly SW, Oakes D, et al
     Safety of rasagiline in elderly patients with Parkinson disease.
     Neurology. 2006;66:1427-9.
     PubMed     Related articles    Abstract available
     
     
     
180. SWARZTRAUBER K , Koudelka C, Brodsky MA
     Initial pharmacotherapy in a population of veterans with Parkinson disease.
     Neurology. 2006;66:1425-6.
     PubMed     Related articles    Abstract available
     
     
     
181. SHIELDS DC , Lam S, Gorgulho A, Emerson J, et al
     Eyelid apraxia associated with subthalamic nucleus deep brain stimulation.
     Neurology. 2006;66:1451-2.
     PubMed     Related articles   
     
     
     April 2006
182. GRAFTON ST , Turner RS, Desmurget M, Bakay R, et al
     Normalizing motor-related brain activity: subthalamic nucleus stimulation in Parkinson disease.
     Neurology. 2006;66:1192-9.
     PubMed     Related articles    Abstract available
     
     
     
183. LO SE , Jain S
     Patient page. Slowing down a "slow" movement disorder: selegiline's benefit in treating Parkinson disease.
     Neurology. 2006;66:E28-9.
     PubMed     Related articles   
     
     
     
184. MCCLUSKEY LF
     Camptocormia: pathogenesis, classification, and response to therapy.
     Neurology. 2006;66:1285-6.
     PubMed     Related articles   
     
     
     
185. HERSHEY T , Mink JW
     Using functional neuroimaging to study the brain's response to deep brain stimulation.
     Neurology. 2006;66:1142-3.
     PubMed     Related articles   
     
     
     
186. KLEIN C , Grunewald A, Hedrich K
     Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.
     Neurology. 2006;66:1129-30.
     PubMed     Related articles   
     
     
     
187. HERNAN MA , Logroscino G, Garcia Rodriguez LA
     Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease.
     Neurology. 2006;66:1097-9.
     PubMed     Related articles    Abstract available
     
     
     
188. MIYASAKI JM , Shannon K, Voon V, Ravina B, et al
     Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2006;66:996-1002.
     PubMed     Related articles    Abstract available
     
     
     
189. PAHWA R , Factor SA, Lyons KE, Ondo WG, et al
     Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2006;66:983-95.
     PubMed     Related articles    Abstract available
     
     
     
190. SUCHOWERSKY O , Gronseth G, Perlmutter J, Reich S, et al
     Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2006;66:976-82.
     PubMed     Related articles    Abstract available
     
     
     
191. SUCHOWERSKY O , Reich S, Perlmutter J, Zesiewicz T, et al
     Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2006;66:968-75.
     PubMed     Related articles    Abstract available
     
     
     
192. ALBIN RL
     Practice Parameters for Parkinson disease: signposts for clinical research.
     Neurology. 2006;66:966-7.
     PubMed     Related articles   
     
     
     
193. MENDELL JR , Clark KR
     Risks, benefits, and consent in the age of gene therapy.
     Neurology. 2006;66:964-5.
     PubMed     Related articles   
     
     
     
194. SUCHOWERSKY O , Gronseth G, Perlmutter J, Reich S, et al
     Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
195. ALBIN RL
     Practice Parameters for Parkinson disease.
     Neurology. 2006;.
     PubMed     Related articles   
     
     
     
196. PAHWA R , Factor SA, Lyons KE, Ondo WG, et al
     Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
197. MIYASAKI JM , Shannon K, Voon V, Ravina B, et al
     Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
198. SUCHOWERSKY O , Reich S, Perlmutter J, Zesiewicz T, et al
     Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     March 2006
199. IWASAKI Y , Ikeda K, Igarashi O, Baba S, et al
     Depression is associated with impairment of ADL, not motor function in Parkinson disease.
     Neurology. 2006;66:956.
     PubMed     Related articles   
     
     
     
200. NOYES K , Liu H, Holloway RG
     What is the risk of developing parkinsonism following neuroleptic use?
     Neurology. 2006;66:941-3.
     PubMed     Related articles    Abstract available
     
     
     
201. POSTUMA RB , Lang AE, Massicotte-Marquez J, Montplaisir J, et al
     Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.
     Neurology. 2006;66:845-51.
     PubMed     Related articles    Abstract available
     
     
     December 2005
202. INZELBERG R , Hattori N, Mizuno Y
     Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
     Neurology. 2005;65:1843.
     PubMed     Related articles   
     
     
     
203. MARTIGNONI E , Cosentino M, Ferrari M, Porta G, et al
     Two patients with COMT inhibitor-induced hepatic dysfunction and UGT1A9 genetic polymorphism.
     Neurology. 2005;65:1820-2.
     PubMed     Related articles    Abstract available
     
     
     November 2005
204. IYER SS , Morgan JC, Sethi KD
     Absorption of orally disintegrating carbidopa-levodopa requires intact small bowel function.
     Neurology. 2005;65:1507.
     PubMed     Related articles   
     
     
     
205. NYHOLM D , Jansson R, Willows T, Remahl IN, et al
     Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
     Neurology. 2005;65:1506-7.
     PubMed     Related articles   
     
     
     
206. IRIZARRY MC , Gurol ME, Raju S, Diaz-Arrastia R, et al
     Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
     Neurology. 2005;65:1402-8.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: